SEOUL (Reuters) - South Korea's drug safety ministry said on Thursday that Russia's Sputnik V coronavirus vaccine and a shot developed by Novavax have been submitted for preliminary regulatory approval.
(Reporting by Hyonhee Shin; editing by John Stonestreet)
Already a subscriber? Log in.
Win a prize this Mother's Day by subscribing to our annual plan now! T&C applies.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!